Alexandra Kropotova
Förmögenhet: 151 040 $ per 2026-07-31
Förmögenhet: 151 040 $ per 2026-07-31
Alexandra Kropotova is currently an Independent Director at iBio, Inc. since 2020 and Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2022.
Formerly, Dr. Kropotova worked at Pfizer Inc. from 2002 to 2007 as Director & Head-Global Clinical Respiratory, at Sanofi from 2007 to 2016 as Vice President-Strategy & Head-Strategic Planning, and at Teva Pharmaceuticals, Inc. from 2016 to 2022 as VP-Global Specialty Research & Development.
Education includes an MBA from Ohio University Graduate College and a doctorate from Pacific State Medical University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-25 | 42 308 ( 0,06 % ) | 151 040 $ | 2026-07-31 | |
IBIO, INC. -.--% | 2025-11-20 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| IBIO, INC. | Direktör/Styrelseledamot | 2020-10-14 |
| SAB BIOTHERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-06-06 |
| Företag | Position | Slut |
|---|---|---|
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Företagsledare/Principal | 2022-06-01 |
| SANOFI | Företagsledare/Principal | 2016-01-01 |
| PFIZER INC. | Direktör/Styrelseledamot | 2007-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Ohio University Graduate College
Ohio University Graduate College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån